โšกToday
โœจToday's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease๐ŸŽˆFor kidsSouth Carolina tract beside wildlife refuge to be permanently conserved๐ŸŒฟNatureFormer ocean liner S.S. United States becomes the world's largest artificial reefโšฝSportsLindy Duncan wins her first LPGA title on attempt 222๐ŸŽจCulture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately Held๐Ÿ”ฌScience & healthPeople who control HIV without treatment may help find a cure๐Ÿ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joined๐Ÿ›๏ธPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressure๐Ÿš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Low-dose anti-aging drug improves brain blood flow in at-risk adults

ScienceDaily 6 November 2026 2 min read

โฎ BeforeBlood flow in the brains of middle-aged adults with the APOE4 variant can decline years before symptoms.
โœ… NowA four-week course of low-dose rapamycin improved that blood flow in a study of healthy adults.

In short

  • Four weeks of low-dose rapamycin improved brain blood flow in healthy middle-aged adults.
  • The participants carried APOE4, a gene variant linked to higher Alzheimer's risk.
  • Women showed the strongest benefits, according to the study's findings.

Why it's good news

Declining blood flow can occur years before Alzheimer's symptoms begin, so improving it early could matter. This study reports a short, four-week trial in people without symptoms, and it does not show the drug prevents or delays the disease. Further research would be needed before anyone could expect a preventive benefit.

Advertisement

From ScienceDaily

A surprising new study suggests that an anti-aging drug could help protect people genetically predisposed to Alzheimer's disease. Researchers found that just four weeks of low-dose rapamycin improved brain blood flow in healthy middle-aged adults carrying the high-risk APOE4 gene variant, with women showing the strongest benefits. Because declining blood flow can occur years before Alzheimer's symptoms appear, the discovery raises hopes for preventing or delaying the disease before memory loss begins.

Read the full story at ScienceDaily Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor